Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

105.44 +1.53 (+1.47%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
3 Stocks With Huge Catalysts on the Way
Big news could mean big boosts for these stocks. 
Via The Motley Fool
The Top 3 Biotech Stocks to Watch in 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023. 
Via InvestorPlace
2 Beaten-Down Growth Stocks to Buy in April
These companies have lucrative opportunities ahead. 
Via The Motley Fool
1 Risky Growth Stock Wall Street Says Is Poised for a 47% Rally
Its price should keep rising, but perhaps Wall Street is a bit enthusiastic with its forecasts. 
Via The Motley Fool
The Top Healthcare Stocks to Buy With $100
A small investment now may bring big results over time. 
Via The Motley Fool
Could Axsome Therapeutics Stock Help You Become a Millionaire?
In the past five years, the stock has risen by nearly 2,400%. 
Via The Motley Fool
Is It Too Late to Buy Axsome Therapeutics Stock?
With two major catalysts in the rearview mirror, it's easy to think that it's too late. 
Via The Motley Fool
What 10 Analyst Ratings Have To Say About Axsome Therapeutics
Via Benzinga
Expert Ratings for Axsome Therapeutics
Via Benzinga
Is Axsome Therapeutics Stock a Buy Now?
The biotech made major progress on the regulatory front last year. 
Via The Motley Fool
Better Growth Stock: Axsome vs. CRISPR Therapeutics
These companies are both in the early days of their growth stories. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
These Up-and-Coming Stocks Are Screaming Buys Right Now
Both companies could deliver revenue and share price growth over the long term. 
Via The Motley Fool
Can Axsome Hold Out Till Depression Drug Becomes a Blockbuster?
Has the company bitten off more than it can chew in R&D, or will its depression drug launch it into the stratosphere? 
Via The Motley Fool
A New Nasdaq Bull Market Is Nearly Here: 3 Stocks to Buy Sooner Rather Than Later
These stocks share one big thing in common -- huge growth prospects. 
Via The Motley Fool
Has Axsome Therapeutics Become a No-Brainer Buy?
The stock has been red-hot over the past year, and analysts remain bullish on it. 
Via The Motley Fool
Axsome Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Analyst Expectations for Axsome Therapeutics's Future
Via Benzinga
Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today
Macro headwinds are weighing on risk-laden biotech stocks today. 
Via The Motley Fool
2 Top Biotech Stocks to Buy in April
Right now you can pick up these stocks on the dip. 
Via The Motley Fool
3 Surprisingly Underrated Stocks to Buy in April
These drugmakers could deliver greater gains than many investors expect. 
Via The Motley Fool
The Top Healthcare Stocks to Buy With $100
With the right stocks, even a small investment can yield huge returns. 
Via The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. 
Via InvestorPlace
3 Up-and-Coming Growth Stocks to Buy Right Now
These companies are small now but could grow much larger over time. 
Via The Motley Fool
2 Biotech Stocks That Could Make You Richer
One is a well-established, large-cap drugmaker, while the other is still making a name for itself in the industry. 
Via The Motley Fool
Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money
There are no guarantees that any stock will generate huge returns. But the odds look pretty good for these three growth stocks. 
Via The Motley Fool
Biotech Stocks And The SVB Collapse — Here's What We Know
The collapse of SVB will have a big impact on early-stage, venture-backed companies. 
Via Investor's Business Daily
3 Nasdaq Stocks on Watch This Week
These three Nasdaq stocks are poised to make big moves in the coming week. 
Via The Motley Fool
5 Top Stocks for March
These five businesses are worth a look for patient investors. 
Via The Motley Fool
Axsome Therapeutics (AXSM) Q4 2022 Earnings Call Transcript
AXSM earnings call for the period ending December 31, 2022. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback